Kezar Life Sciences, Inc. (KZR)
7.29
0.00 (0.00%)
USD |
NASDAQ |
Oct 02, 16:00
Kezar Life Sciences EPS Diluted (Quarterly) : -0.7838 for March 31, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -0.7838 |
| December 31, 2025 | -1.985 |
| September 30, 2025 | -1.533 |
| June 30, 2025 | -1.874 |
| March 31, 2025 | -2.266 |
| December 31, 2024 | -2.770 |
| September 30, 2024 | -2.784 |
| June 30, 2024 | -2.958 |
| March 31, 2024 | -2.975 |
| December 31, 2023 | -4.435 |
| September 30, 2023 | -3.179 |
| June 30, 2023 | -3.355 |
| March 31, 2023 | -3.069 |
| December 31, 2022 | -2.517 |
| September 30, 2022 | -2.474 |
| June 30, 2022 | -2.518 |
| March 31, 2022 | -2.643 |
| December 31, 2021 | -2.539 |
| September 30, 2021 | -2.779 |
| Date | Value |
|---|---|
| June 30, 2021 | -2.497 |
| March 31, 2021 | -2.545 |
| December 31, 2020 | -2.185 |
| September 30, 2020 | -2.258 |
| June 30, 2020 | -2.212 |
| March 31, 2020 | -3.046 |
| December 31, 2019 | -5.009 |
| September 30, 2019 | -4.791 |
| June 30, 2019 | -4.571 |
| March 31, 2019 | -4.013 |
| December 31, 2018 | -3.042 |
| September 30, 2018 | -2.988 |
| June 30, 2018 | -33.10 |
| March 31, 2018 | -2.594 |
| December 31, 2017 | -1.204 |
| September 30, 2017 | -1.088 |
| June 30, 2017 | -0.9839 |
| March 31, 2017 | -1.183 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| NovelStem International Corp. | -0.0017 |
| Brainstorm Cell Therapeutics, Inc. | -0.3494 |
| Summit Therapeutics, Inc. | -0.2772 |
| Protara Therapeutics, Inc. | -0.3552 |
| Clene, Inc. | -1.084 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.756M |
| Total Expenses (Quarterly) | 5.756M |
| Enterprise Value | -11.12M |
| Earnings Yield | -84.73% |
| Normalized Earnings Yield | -74.78 |